HCA Healthcare Inc (NYSE:HCA)
$ 369.82 -1.36 (-0.37%) Market Cap: 82.04 Bil Enterprise Value: 134.27 Bil PE Ratio: 12.72 PB Ratio: 0 GF Score: 91/100

Q2 2025 HCA Healthcare Inc Earnings Call Transcript

Jul 25, 2025 / 02:00PM GMT
Release Date Price: $334.32 (-2.10%)

Key Points

Positve
  • HCA Healthcare Inc (HCA) reported a strong financial performance for the second quarter of 2025, with a 24% increase in diluted earnings per share to $6.84.
  • The company experienced solid revenue growth of 6.4%, driven by increased demand for services, improved payer mix, and consistent patient acuity levels.
  • HCA Healthcare Inc (HCA) improved quality outcomes, throughput measures in emergency rooms, and patient satisfaction during the quarter.
  • The company increased its 2025 guidance, reflecting a positive demand environment and the effectiveness of strategic initiatives.
  • HCA Healthcare Inc (HCA) maintained a strong balance sheet and executed a balanced capital allocation strategy, including $4.2 billion in cash flow from operations and $2.5 billion in share repurchases.
Negative
  • Medicaid volumes were down slightly, and self-pay volumes were below expectations, representing the lowest reimbursing payers.
  • The company anticipates some people will lose insurance coverage due to the expiration of enhanced premium tax credits, which could impact financial performance.
  • HCA Healthcare Inc (HCA) faces challenges from the One Big Beautiful Bill Act, which includes potential adverse impacts from Medicaid components and exchange provisions.
  • The company experienced underperformance in a couple of markets, which offset some of the better performance in hurricane-affected markets.
  • Supply expenses increased slightly as a percentage of revenue due to increased spending on cardiac-related devices.
Operator

Ladies and gentlemen, welcome to HCA Healthcare second-quarter 2025 earnings conference call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank Morgan. Please go ahead, sir.

Frank Morgan
HCA Healthcare Inc. - Vice President-Investor Relations

Good morning and welcome to everyone on today's call. With me this morning is our CEO, Sam Hazen; and our CFO, Mike Marks. Sam and Mike will provide some prepared remarks, and then we'll take questions.

Before I turn the call over to Sam, let me remind everyone that should today's call contain any forward-looking statements, they're based on management's current expectations. Numerous risks, uncertainties, and other factors may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements and these factors are listed in today's press release and in our various SEC filings.

On this morning's call, we may reference

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot